Home›Search›Anti-Cancer Drugs

Anti-Cancer Drugs

Lippincott Williams and Wilkins · United States

ISSN0959-4973eISSN1473-5741

SJR Q3✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.506

H-Indexi

113

SNIPi

0.421

Total Worksi

5,067

Total Citationsi

106,693

2yr Mean Citednessi

1.69

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Oncology; Pharmacology & Pharmacy; Pharmacology; Pharmacology (medical); Cancer Research.

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

FrequencyTen No. A Year

StatusActive

Total Publications5,067

Publisher OrgLippincott Williams & Wilkins

Visit Journal Website

Submission Info

Publishing ModelSubscription

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Lippincott Williams and Wilkins

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0959-4973 / 1473-5741

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

140

2019

146

1.8k

2020

239

2.4k

2021

206

1.6k

2022

460

2023

106

350

2024

120

184

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ3

PharmacologyQ3

Pharmacology (medical)Q3

Cancer ResearchQ4

Subject Classification

Web of Science Categories

OncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Cancer ResearchOncology

Research Topics (OpenAlex)

Cancer therapeutics and mechanismsCancer Treatment and PharmacologyColorectal Cancer Treatments and StudiesLung Cancer Treatments and MutationsLung Cancer Research Studies

Frequently asked questions about Anti-Cancer Drugs

Is Anti-Cancer Drugs a predatory journal?

PubScope has no integrity flags on record for Anti-Cancer Drugs: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Anti-Cancer Drugs?

Anti-Cancer Drugs is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.69.

Is Anti-Cancer Drugs indexed in Scopus and Web of Science?

Anti-Cancer Drugs is indexed in Web of Science, Scopus.

What is the aims and scope of Anti-Cancer Drugs?